Lophos Holdings Inc., owner of a biosciences business licensed for the cultivation, research and sale of Peyote and other controlled substances, has received approval for the listing of its common shares on the Canadian Securities Exchange (CSE). 

The company expects to start trading on the CSE around September 6, 2023, under the ticker symbol "MESC".

The company, whose main business is the indoor cultivation, research and sale of Lophophora williamsii -aka Peyote cactus, holds a Canadian Controlled Substances Dealer’s License enabling it to sell the psychedelic through an exemption to the country’s Controlled …

Full story available on Benzinga.com

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.